JIP
GILD icon

JBJ Investment Partners’s Gilead Sciences GILD Stock Holding History

JBJ Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-602
Closed -$39K – 106
2019
Q1 		$39K Buy
+602
New +$40K 0.01% 101

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JBJ Investment Partners's GILD Position: Q2 2019 in Review

JBJ Investment Partners sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 602 shares — an estimated $39K sold.

JBJ Investment Partners first reported a position in GILD in Q1 2019 and held it in 1 quarter. The position peaked at $39K in Q1 2019. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • JBJ Investment Partners reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
  • JBJ Investment Partners sold 602 Gilead Sciences shares in Q2 2019, an estimated $39K.
  • JBJ Investment Partners first reported a position in Gilead Sciences in Q1 2019 and held it in 1 quarter.
  • JBJ Investment Partners's Gilead Sciences position peaked at $39K in Q1 2019.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on JBJ Investment Partners's 13F filing for Q2 2019, filed 25 Jul 2019.